
Mustang Bio (MBIO) Earnings Dates & Reports
Mustang Bio (MBIO) Most Recent Earnings
Report DateMar 28, 2025
Period EndingQ4 2024
Est. EPS-$8
Actual EPS-$0.94
EarningsBeat
Mustang Bio (MBIO) Earnings
View the latest Mustang Bio (MBIO) earnings report, listen to the earnings call, and analyze historical earnings performance with AI-powered insights.
Start investing in Mustang Bio (MBIO)
Order type
Buy in
Order amount
Est. shares
0 shares
Mustang Bio (MBIO) Earnings per Share (EPS) History
Signup for full accessBrowse free
Mustang Bio (MBIO) Latest Earnings
The value each MBIO share was expected to gain vs. the value each share gained.
Mustang Bio (MBIO) reported its most recent earnings on Mar 28, 2025 for Q4 2024, posting earnings per share (EPS) of -$0.94. This exceeded analysts' expectations of -$8 by 88.25%, marking a Beat.
For comparison, Mustang Bio reported EPS of -$35.50 in the same quarter last year.
The company is expected to announce its next earnings report on 11/07/2025, with analysts projecting an EPS of $0.
Mustang Bio (MBIO) Earnings History
Mustang Bio (MBIO) Earnings Related Price Changes
Earnings announcements may impact a stock’s price. This table highlights the Mustang Bio’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.
Report date | Price 1D before | Price 1D after | Change |
---|---|---|---|
Aug 8, 2025 | — | — | — |
May 14, 2025 | — | — | — |
Mar 28, 2025 | — | — | — |
Nov 8, 2024 | — | — | — |
Mustang Bio (MBIO) Earnings FAQs
Mustang Bio (MBIO) last reported earnings on Mar 28, 2025 for Q4 2024, posting an EPS of -$0.94, which Beat the estimate of -$8 by 88.25%.
For Q4 2024, Mustang Bio (MBIO) reported an EPS of -$0.94, exceeding analysts' estimate of -$8 by 88.25%.
For Q4 2024, Mustang Bio (MBIO) Beat expectations with an actual EPS of -$0.94 vs. an estimated EPS of -$8.
Following the last earnings report on Mar 28, 2025, Mustang Bio (MBIO)'s stock price moved — from — to —.
The next Mustang Bio (MBIO) earnings call is scheduled for Nov. 7, 2025, where executives will discuss financial results and outlook.